Hyo-In Rhyou
Overview
Explore the profile of Hyo-In Rhyou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rhyou H, Kim H, Song W, Lee S, Kim S, Kwon J, et al.
World Allergy Organ J
. 2024 Sep;
17(9):100957.
PMID: 39252792
Background: Anti-type 2 (T2) biologic therapies (biologics) improve exacerbation rates, lung function, and asthma-related quality of life (QoL) in patients with severe T2 asthma. However, studies comparing different biologics are...
2.
Rhyou H, Nam Y
J Asthma Allergy
. 2022 Oct;
15:1337-1345.
PMID: 36189190
Purpose: Drug hypersensitivity is an adverse drug reaction mediated by immunological mechanisms and is accompanied by a significant socioeconomic burden. The drug provocation test (DPT) is the gold standard for...
3.
Rhyou H, Nam Y, Park H
Allergy Asthma Immunol Res
. 2022 Mar;
14(2):153-167.
PMID: 35255534
Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (NERD) is a unique condition characterized by aspirin/NSAID hypersensitivity, adult-onset asthma, and/or chronic rhinosinusitis with nasal polyps. Arachidonic acid metabolism dysregulation and intense eosinophilic/type...
4.
Rhyou H, Han S, Nam Y
Allergy Asthma Clin Immunol
. 2021 Nov;
17(1):117.
PMID: 34784964
Background: Bullous pemphigoid (BP) is a potentially life-threatening autoimmune blistering disease which is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. In recent years, the role...
5.
Rhyou H, Nam Y, Kim S, Doo G, Ha C, Nam H, et al.
PLoS One
. 2021 Jul;
16(7):e0254898.
PMID: 34293048
Cefaclor, a second-generation oral cephalosporin, is the most frequently prescribed cephalosporin in Korea. Studies, however, have yet to analyze the incidence of cefaclor-associated adverse drug reactions (ADRs), including hypersensitivity (HS),...
6.
Rhyou H, Bae W, Nam Y
Ann Allergy Asthma Immunol
. 2021 Jul;
127(6):697-699.
PMID: 34216795
No abstract available.
7.
Rhyou H, Bae W, Nam Y
J Asthma Allergy
. 2021 Apr;
14:309-316.
PMID: 33833532
Purpose: Chronic rhinosinusitis (CRS) and allergic rhinitis (AR) are common asthma-associated upper airway diseases. Olfactory dysfunction, a common symptom among these patients, is an increasingly recognized condition that is associated...
8.
Rhyou H, Doo G, Yoon J, Ha C, Nam H, Woo S, et al.
Allergy Asthma Clin Immunol
. 2021 Feb;
17(1):20.
PMID: 33588929
Background: Cefaclor, a second-generation oral cephalosporin, is widely prescribed to treat infectious diseases. Immediate hypersensitivity (HS) reactions to cefaclor have continuously been reported and are expected to increase with its...
9.
Rhyou H, Nam Y
Ann Allergy Asthma Immunol
. 2020 Aug;
126(1):69-74.
PMID: 32858237
Background: Cognitive deficits are associated with asthma globally; however, the association between cognitive function and asthma has not been fully elucidated. Objective: To assess the relationship between asthma and cognitive...
10.
Rhyou H, Nam Y
Ann Allergy Asthma Immunol
. 2020 May;
125(2):177-181.
PMID: 32371244
Background: Asthma is characterized by chronic airway inflammation, and inhaled corticosteroids (ICSs) have been recommended as first-line treatment. However, response to ICS treatment is various, and the prediction of response...